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The  Director  of  the  National  Institutes  of  Health  shall  
require that all investigators funded by the NIH submit or 
have  submitted  for  them  to  the  National  Library  of  Medi-
cine’s PubMed  Central  an electronic version of their final, 
peer-reviewed manuscripts upon acceptance for publication, 
to be made publicly available no later than 12 months after 
the official date of publication: Provided, That the NIH shall 
implement the public access policy in a manner consistent 
with copyright law. 
US Consolidated Appropriations Act, 2008
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HE  DAY  AFTER  CHRISTMAS  IN  2007,  US 
President George W. Bush signed an omnibus 
spending bill containing a provision requiring 
the US National Institutes of Health (NIH) to mandate 
open  access  for  NIH-funded  research  beginning  on  7 
April  2008.1 Measured  by  the  ferocity  of  opposition 
overcome and the volume of literature liberated, this is 
the largest victory so far in the open access movement.  
  The new NIH policy2 is groundbreaking for a handful 
of reasons. First, it is the first open access mandate for a 
major public funding agency in the United States; it is 
also the first one for a public funding agency anywhere 
in the world that was demanded by the national legisla-
ture rather than initiated and adopted independently by 
the agency. 
  The NIH mandate comes after a long struggle. The 
US Congress asked for an open access mandate for the 
NIH in 2004, but in 2005 the agency decided to request 
rather  than  require  that  its  researchers  deposit  their 
work  in  open  access  repositories. Open  access  propo-
nents  have  worked  tirelessly  ever  since  to  persuade 
Congress to strengthen the  policy. Open access oppo-
nents have worked just as hard, first to keep the policy 
weak and then to help the weak policy succeed in order 
to head off pressure for a stronger policy.3 
  Second,  despite  being  frustratingly  laborious,  the 
process sets an important precedent. Other US agencies 
no longer have to worry that a strong open access policy 
will  antagonize  Congress  or  the  White  House.  Some 
agencies will see the congressional bill as a green light 
to adopt similar policies of their own; others will wait to 
see how the NIH policy fares in court. 
  Third, the sheer size of the NIH makes the new pol-
icy important. The NIH is the world’s largest funder of 
scientific  research,  not  counting  classified  military 
research. Its budget last year, US$28 billion, was larger 
than  the  gross  domestic  product  of  142  nations  and 
more than 5 times larger than the combined budgets of 
the  7  UK  research  councils.  NIH-funded  research  re-
sults in 80 000 peer-reviewed articles per year, or 219 
per day.4 The NIH open access mandate not only frees 
up an unprecedented quantity of high-quality medical 
research,  but  also  cultivates  new  expectations  among 
researchers,  funders,  governments  and  voters  that 
publicly funded research should be open access.  
  Finally, the policy is strong. The mandatory deposit 
policy will drive compliance toward 100% (it was a dis-
mal 4% after the first year of operation under the 2005 
voluntary  policy5).  The  bill  requires  deposit  of  manu-
scripts in an open access repository (PubMed Central) 
immediately upon acceptance by a peer-reviewed jour-
nal. This is much better than requiring deposit during or 
after  a  12-month  embargo  period.  Immediate  deposit 
allows  immediate  release  of  metadata,  which  will  en-
hance the article’s visibility and allow the NIH to move 
the article from closed to open access status automati-
cally as soon as the embargo period ends. NIH staffers 
will no longer have to hunt down the author and beg for a 
copy of his or her year-old manuscript.6,7 
  There are some drawbacks to the new policy, such as 
the  allowance  for  an  embargo  period  of  up  to  12 
months. Any embargo compromises the public interest, 
and  longer  embargoes  are  more  harmful  in  medicine 
than in other fields. However, a mandate is better than 
a shortened embargo, if we have to choose. The reason 
is simply that a short embargo without a mandate is not 
really  short,  because  there  is  no  enforceable  deadline 
for  ending  the  embargo  and  providing  open  access.
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Table 1: Common misconceptions about the new NIH open access policy  
Fiction  Fact 
The mandate is to publish in open access journals.  The mandate is to deposit in an open access repository 
(PubMed Central). 
The mandate is to bypass journals and peer re-
view. 
The mandate is to provide open access to articles 
already published in peer-reviewed journals. 
The mandate applies to the published version of 
articles.  
The mandate applies to the final versions of the 
authors’ peer-reviewed manuscripts.  
The mandate directs deposits to PubMed.  The mandate directs deposits to PubMed Central. 
The mandate requires a 12-month embargo on the 
copy in PubMed Central. 
The mandate permits an embargo of up to 12 months 
on the copy in PubMed Central.  
The new NIH budget is US$29 million.   The new NIH budget is US$29 billion. 
The new mandate will last for only 1 year.   The new mandate will last indefinitely. 
The mandate requires violation of copyright law.  The mandate requires compliance with copyright law. 
 
Moreover,  we  do  not  have  to  choose  between  the  2 
options;  we  can  make  a  shorter  embargo  period  our 
next goal. 
  A lawsuit by a publisher could delay the implementa-
tion of NIH’s new open access policy. However, the only 
legal  objection  that  publishers  have  raised  to  date  is 
that the policy will violate copyright, and the wording of 
the policy decisively answers this objection. Under the 
new rules,  when NIH grantees publish an article in  a 
journal,  they  will  retain  the  right  to  comply  with  the 
NIH policy, even if they transfer all of their other rights 
to the publisher. Publishers cannot complain that com-
pliance with the NIH policy violates a right they pos-
sess,  only  that  it  violates  a  right  they  might  wish  to 
possess. Moreover, of course, in any lawsuit the NIH’s 
case will be strengthened by the fact that Congress and 
the  President  ordered  the  agency  to  adopt  an  open 
access mandate. 
  How  will  the  NIH  deal  with  conflicts  between  its 
open access mandate and the policies of publishers to 
whom NIH grantees submit work? The policy does not 
depend on publisher consent or cooperation; it simply 
requires grantee compliance. If a  publisher refuses  to 
accommodate the NIH policy, then authors must look 
for  another  publisher.2  The  NIH  will  ensure  that  its 
grantees comply with the  policy by requiring them  to 
cite  the  submission  reference  number  assigned  by 
PubMed Central for any of their previous papers cov-
ered by the policy, when they submit progress reports 
or apply for new grants. Noncompliance may “delay or 
prevent” the awarding of funds.4 
   The new NIH policy, like the old one, allows grantees 
to use grant  funds to  pay the publication fees at fee-
based open access  journals.  The policy applies to “all 
graphics  and  supplemental  materials  that  are  associ-
ated with the article.” Data files are exempt from  the 
new policy but continue to fall under the NIH’s 2003 
data sharing policy.8  
  In  the  short  time  since  President  Bush  signed  the 
omnibus spending bill there have been various miscon-
ceptions about what has taken place (see Table 1). These 
misunderstandings no longer function as impediments 
to legislation, but they could well function as impedi-
ments to implementation. It is incumbent upon all of us 
to correct them to ensure that authors’ support for and 
compliance with the legislation are not undermined by 
misinformation.  
  In Canada the open access policy for research funded 
by  the  Canadian  Institutes  of  Health  Research8  is 
stronger  than  the  NIH  policy  in  2  respects:  it  allows 
only a 6-month embargo and it also applies to datasets. 
However, in another respect it is considerably weaker 
than the  NIH policy: it applies  only “where allowable 
and in accordance with publisher policies.”9  
  The road to the new NIH policy has been a long and 
difficult one, but now that we have reached its end we 
can see a new world ahead of us. We are moving from a 
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exclusively by expensive journals, where only research-
ers lucky enough to work at affluent institutions can see 
it, to a world in which most publicly funded research is 
freely available to everyone who can make use of it. We 
are not there yet, I realize. However, before 2008, more 
than 30 other funding agencies worldwide had already 
mandated open access for the research they fund (their 
policies are available in ROARMAP, the registry of open 
access  repository  material  archiving  policies,  at 
www.eprints.org/openaccess/policysignup/)  and  now 
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Editors’ note: This article is based on the author's commentary “The 
Mandates of January,” which appeared in the 2 Feb. 2008 issue of the 
SPARC Open Access Newsletter
 (www.earlham.edu/~peters/fos/news 
letter/02-02-08.htm#mandates). 
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